Emphysema Devices Search for Breathing Room

Article preview from Medtech Insight - March 2009

Interventional pulmonology is a burgeoning field for medical device manufacturers. It is ripe with opportunities to develop minimally invasive solutions for patients with chronic progressive lung disease. Emphysema, which afflicts close to 2% of the world's population, is a prime target. With an opportunity as large as this driving innovation and investment, the right combination of technology and clinical trial design could spell blockbuster success for medtech companies.